GlassScriptPhysician profile
Danielle T Kleinhans
NPI 1033724869
$346.79
in general payments reported to CMS, 2019-2025
10 companies · $81.29 in 2025
The $81.29 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.73 · 2022: $157 · 2023: $50.56 · 2024: $39.03 · 2025: $81.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $170.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $138.88 | 2022 | |
| Janssen Pharmaceuticals, INC | $30.07 | 2023 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $28.99 | 2025 | Gattex |
| Advanced Oxygen Therapy INC. | $27.36 | 2025 | Topical Oxygen Chamber For Extremities |
| Tactile Systems Technology INC | $24.94 | 2025 | Nimbl, Flexitouch Plus |
| Smith+Nephew, INC. | $20.49 | 2023 | Pico 7 |
| Acera Surgical, INC. | $20.05 | 2024 | Restrata Wound Matrix |
| Hologic Sales and Service, LLC | $18.98 | 2024 | Trident Specimen Radiography System, Trunode, Localizer |
| Medline Industries LP | $18.73 | 2021 | |
| Convatec INC. | $18.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Kleinhans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.